Vimarsana
Biggest News Aggregation in the World

Page 6 - Be Limited News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Be Limited. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Be Limited Today - Breaking & Trending Today

Biological E. cuts price of Corbevax vaccine to Rs 250 per dose - Vimarsana News

Biological E. cuts price of Corbevax vaccine to Rs 250 per dose

For the end user, the price would be Rs.400 a dose, including taxes and administration charges

Covid vaccination: Price of Corbevax dose reduced from Rs 840 to Rs 250 - Vimarsana News

Covid vaccination: Price of Corbevax dose reduced from Rs 840 to Rs 250

Covid vaccination: Price of Corbevax dose reduced from Rs 840 to Rs 250 - Corbevax is currently being administered to children in the age group of 12-14.

Biological E's Corbevax gets DCGI nod for emergency use in 5-12 year-olds - Vimarsana News

Biological E's Corbevax gets DCGI nod for emergency use in 5-12 year-olds

Vaccine manufacturer Biological E. Limited today said that its COVID-19 vaccine Corbevax has received emergency use authorisation from the Drugs Controller General of India (DCGI) for the 5-12-year age group.

Hyderabad's Biological E to get mRNA technology from WHO to produce Covid vaccines - Vimarsana News

Hyderabad's Biological E to get mRNA technology from WHO to produce Covid vaccines

Biological E and the Indian government will work together with WHO and their partners to develop a roadmap for producing mRNA vaccines as soon as possible. At present, India has no Covid-19 vaccine made on mRNA platform.

CORBEVAXTM Receives EUA for 12-18 Age Group - Vimarsana News

CORBEVAXTM Receives EUA for 12-18 Age Group

Hyderabad: Biological E. Limited (BE), one of the world’s largest vaccine manufacturers, has today announced that itsCORBEVAXTM vaccine, which is India's first indigenously developed Receptor Binding Domain (RBD) Protein sub-unit vaccine against COVID-19, has received emergency use authorization (EUA) from India's drug regulator for the 12 to 18-year age group. The Drugs

Source: sakshi.com